[HTML][HTML] ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature

AL Komaroff, WI Lipkin - Frontiers in Medicine, 2023 - frontiersin.org
Some patients remain unwell for months after “recovering” from the acute COVID-19. They
develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and …

Pathophysiology of Post-COVID syndromes: a new perspective

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb, NN Welson - Virology Journal, 2022 - Springer
Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19

C Matsumoto, S Shibata, T Kishi, S Morimoto… - Hypertension …, 2023 - nature.com
Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

Pituitary and SARS CoV-2: an unremitting conundrum

C Capatina, C Poiana, M Fleseriu - Best Practice & Research Clinical …, 2023 - Elsevier
There is increased interest related to the impact of coronavirus disease 19 (COVID-19) on
the endocrine system and in particular on the pituitary gland. Over the course of the severe …

Long COVID and pituitary dysfunctions: a bidirectional relationship?

L di Filippo, V Franzese, S Santoro, M Doga, A Giustina - Pituitary, 2024 - Springer
Long COVID is a novel emerging syndrome known to affect multiple health areas in patients
previously infected by SARS-CoV-2 markedly impairing their quality of life. The …

Explaining long COVID: a pioneer cross-sectional study supporting the endocrine hypothesis

T Ach, N Ben Haj Slama, A Gorchane… - Journal of the …, 2024 - academic.oup.com
Context In some patients, symptoms may persist after COVID-19, defined as long COVID. Its
pathogenesis is still debated and many hypotheses have been raised. Objective Our primary …

Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study

TJ Wright, RB Pyles, M Sheffield-Moore… - Molecular and Cellular …, 2024 - Elsevier
Objective To determine if patients that develop lingering neurologic symptoms of fatigue and
“brain fog” after initial recovery from coronavirus disease 2019 (COVID-19) have persistent …

Evidences that SARS-CoV-2 vaccine-induced apoplexy may not be solely due to ASIA or VITT syndrome', commentary on pituitary apoplexy and COVID-19 …

A Taieb, BA Asma, EE Mounira - Frontiers in Endocrinology, 2023 - frontiersin.org
The present commentary aims to discuss certain diagnostic and pathophysiological aspects
of pituitary apoplexy in the case reported by Aliberti et al.(2022)(1). The report states the …

Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19?

N Venugopal, PA Armstrong, TJ Wright… - Best Practice & …, 2023 - Elsevier
The SARS-CoV-2 pandemic created a multitude of medical crossroads requiring real time
adaptations of best practice covering preventative and interventional aspects of care. Among …

Hypopituitarism and COVID-19

G Carosi, A Cremaschi, C Giavoli, E Ferrante… - Pituitary, 2024 - Springer
Purpose This review aims to collect and examine recent research findings regarding
hypopituitarism and COVID-19, focusing on the virus's impact on the pituitary gland and the …